Patients with cystic fibrosis (CF) are repeatedly exposed to antibiotics, especially during the
pulmonary exacerbations of the disease. However, the available therapeutic strategies are …

Pseudomonas aeruginosa is one of the most dominant pathogens in cystic fibrosis (CF)
airway disease and contributes to significant inflammation, airway damage, and poorer …

Background Chronic infection and concomitant airway inflammation is the leading cause of
morbidity and mortality for people living with cystic fibrosis (CF). Although chronic infection in …

The cystic fibrosis (CF) lung microbiome has been studied in children and adults; however,
little is known about its relationship to early disease progression. To better understand the …

Rationale The role bacteria play in the progression of COPD has increasingly been
highlighted in recent years. However, the microbial community complexity in the lower …

Background Pathogen surveillance is challenging but crucial in children with cystic fibrosis—
who are often non-productive of sputum even if actively coughing—because infection and …

Individuals with cystic fibrosis (CF) often acquire chronic lung infections that lead to
irreversible damage. We sought to examine regional variation in the microbial communities …

Bacteria that infect the airways of persons with cystic fibrosis (CF) include a group of well-
described opportunistic pathogens as well as numerous, mainly obligate or facultative …

Abstract Background & Aims The importance of the intestinal microbiota for the onset and
clinical course of many diseases, including liver diseases like non‐alcoholic steatohepatitis …

An increasing body of evidence indicates the relevance of microbiota for pulmonary health
and disease. Independent investigations recently demonstrated that the lung harbors a …